Randy Robinson
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Immunology top 5%
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
- Immunology 13
- Immunotherapy and Immune Responses 4
- T-cell and B-cell Immunology 3
- Oncology 12
- HER2/EGFR in Cancer Research 8
- CAR-T cell therapy research 3
- Co-authors
- Chun‐Wei Chang (3 shared papers)Arnold H. Horwitz (2 shared papers)Marc Better (2 shared papers)Euan Murray (2 shared papers)Norman Davidson (1 shared paper)Ingegerd Hellström (1 shared paper)K E Hellström (1 shared paper)Jane R. Parnes (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Annals of Oncology (2 papers)Human Antibodies (2 papers)The Journal of Immunology (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesAustraliaSwitzerland
In The Last Decade
Randy Robinson
31 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 84
- Radiology, Nuclear Medicine and Imaging 745
- Immunology 431
- Pathology and Forensic Medicine 220
- Oncology 308
- Molecular Biology 731
Countries citing papers authored by Randy Robinson
This map shows the geographic impact of Randy Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randy Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randy Robinson more than expected).
Fields of papers citing papers by Randy Robinson
This network shows the impact of papers produced by Randy Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randy Robinson. The network helps show where Randy Robinson may publish in the future.
Co-authors
The 25 scholars most cited alongside Randy Robinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 441 | |
| 2 | 2013 | 218 | |
| 3 | 1987 | 168 | |
| 4 | Augmentation of antibody dependent cell mediated cytotoxicity following in vivo therapy with recombinant interleukin 2. | 1990 | 130 |
| 5 | 1987 | 122 | |
| 6 | 1983 | 71 | |
| 7 | 1981 | 69 | |
| 8 | 2008 | 54 | |
| 9 | 2021 | 48 | |
| 10 | 1983 | 45 | |
| 11 | 2005 | 29 | |
| 12 | 1987 | 28 | |
| 13 | 2019 | 12 | |
| 14 | 1991 | 12 | |
| 15 | 2024 | 11 | |
| 16 | 2016 | 9 | |
| 17 | 1996 | 9 | |
| 18 | 1990 | 9 | |
| 19 | 2020 | 8 | |
| 20 | 1992 | 8 |
About Randy Robinson
Randy Robinson is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 1.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (11 papers), HER2/EGFR in Cancer Research (8 papers), Immunotherapy and Immune Responses (4 papers), Multiple Sclerosis Research Studies (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Glycosylation and Glycoproteins Research (3 papers), T-cell and B-cell Immunology (3 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (745 citations), Immunology (431 citations), Pathology and Forensic Medicine (220 citations), Oncology (308 citations) and Molecular Biology (731 citations). Randy Robinson has collaborated with scholars based in United States, Australia and Switzerland. Frequent co-authors include Chun‐Wei Chang, Arnold H. Horwitz, Marc Better, Euan Murray, Norman Davidson, Ingegerd Hellström, K E Hellström, Jane R. Parnes, Jonathan G. Seidman and I Hellström. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Human Antibodies, The Journal of Immunology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.